Renhe Pharmacy Co

Renhe Pharmacy Co FCF/Debt

The Free Cash Flow to Debt Ratio of Renhe Pharmacy Co (000650.SZ) as of Oct 18, 2026 is 14,381.48 %. In the previous year, Free Cash Flow to Debt Ratio was 1,691.73 % — a change of 750.11% (higher).

FCF/Debt

14,381.48 %

YoY

750.11%

Last updated:

Free Cash Flow to Debt Ratio of Renhe Pharmacy Co is 2024 14,381.48 % . Free Cash Flow to Debt Ratio of Renhe Pharmacy Co was 2023 1,691.73 % . It decreases by 750.11% higher compared to the previous year.

The Renhe Pharmacy Co FCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF/Debt
Date
FCF/Debt
Jan 1, 2018
274,357.97 CNY
Jan 1, 2019
-743.91 CNY
Jan 1, 2020
1,013.23 CNY
Jan 1, 2021
812.86 CNY
Jan 1, 2022
3,052.16 CNY
Jan 1, 2023
1,691.73 CNY
Jan 1, 2024
14,381.48 CNY
The Renhe Pharmacy Co FCF/Debt history
YEARFCF/DebtYoY
14,381.48 %+750.11%
1,691.73 %-44.57%
3,052.16 %+275.49%
812.86 %-19.78%
1,013.23 %-236.20%
-743.91 %-100.27%
274,357.97 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Renhe Pharmacy Co Stock analysis

What does Renhe Pharmacy Co do? Renhe Pharmacy Co Ltd is a pharmaceutical company based in Nanchang, China, operating within the Health Care sector. The company, listed on the Shenzhen Stock Exchange under ticker 000650.SZ, has been publicly traded since its IPO on December 10, 1996. Renhe Pharmacy employs 6,062 full-time staff and focuses on the manufacturing and distribution of pharmaceutical products. Its product portfolio includes various dosage forms such as capsules, granules, tablets, powders, injections, suppositories, and ointments. The company operates primarily within China, distributing its products domestically. Renhe Pharmacy is engaged in both the industrial manufacturing of pharmaceuticals and the retail and wholesale distribution of health-related products. The firm's headquarters are located in Nanchang, Jiangxi Province, and it maintains a website at https://www.renheyaoye.com/photography, though the content of the site is not detailed here. The company's activities are centered around the production and sale of pharmaceuticals, with no indication of international operations or significant acquisitions beyond the information provided. The business model emphasizes domestic market presence, serving both medical institutions and consumers through its product range. Renhe Pharmacy Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Renhe Pharmacy Co stock

Free Cash Flow to Debt Ratio of Renhe Pharmacy Co is 14,381.48 % in 2024.

Free Cash Flow to Debt Ratio of Renhe Pharmacy Co changed from 1,691.73 % to 14,381.48 %, representing a 750.11% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow to Debt Ratio Renhe Pharmacy Co since 2006 – with annual values, charts, and detailed analysis.

FCF/Debt measures the percentage of total debt that could be repaid from free cash flow. It is a stricter measure than OCF/Debt as it accounts for capital expenditures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Debt Ratio's Renhe Pharmacy Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Renhe Pharmacy Co

All Key Metrics — Renhe Pharmacy Co